Sisi Qin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sisi Qin has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Audrey Regina Valerie
Department of Integrated Biomedical Science, Soonchunhyang Institute of Medi-bio-Science (SIMS), Soonchunhyang University, Cheonan 31151, Republic of Korea
1 shared publication - Gayoung Seo
Department of Integrated Biomedical Science, Soonchunhyang Institute of Medi-bio-Science (SIMS), Soonchunhyang University, Cheonan, Chungcheongnam-do 31151, Republic of Korea; Institute for Molecular Metabolism Innovation, Soonchunhyang University, Asan 31538, Republic of Korea
1 shared publication - Ichiwa Kitty
Department of Integrated Biomedical Science, Soonchunhyang Institute of Medi-bio Science (SIMS), Soonchunhyang University, Cheonan 31151, Chungcheongnam-do, Republic of Korea
1 shared publication - Kenneth Joshua
Department of Integrated Biomedical Science, Soonchunhyang Institute of Medi-bio-Science (SIMS), Soonchunhyang University, Cheonan 31151, Republic of Korea
1 shared publication - Renata Kusuma
Department of Integrated Biomedical Science, Soonchunhyang Institute of Medi-bio-Science (SIMS), Soonchunhyang University, Cheonan 31151, Republic of Korea
1 shared publication - Wootae Kim
Department of Integrated Biomedical Science, Soonchunhyang Institute of Medi-bio Science (SIMS), Soonchunhyang University, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 3 March 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (5) , 2356
Ubiquitin System-Driven Proteostasis in DNA Damage Response
Proteostasis is essential for maintaining the proper function of the proteome and diverse cellular processes. The ubiquitin system plays a central role in proteostasis by regulating protein stability, trafficking, and termination. Under cellular stress, rapid proteome remodeling is required to maintain proteostasis and support adaptive cellular stress-response pathways, including the DNA damage response (DDR). Proper DDR function relies on precise control of protein abundance and signaling dynamics, primarily achieved through ubiquitin-mediated proteostatic regulation involving both proteolytic degradation and non-proteolytic scaffolding function. Dysregulation of the ubiquitin system alters the dynamic control of the DDR cascade, leading to genomic instability and disease progression. Therefore, targeting key components of the ubiquitin system may restore proper DDR signaling regulation and offer novel therapeutic opportunities for disease treatment. In this review, we summarize the role of the ubiquitin system in proteostasis-mediated DDR regulation and explore the potential of targeting ubiquitin system components as therapeutic strategies in cancer treatment.
- 3 March 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (5) , 2356
Open AccessUbiquitin System-Driven Proteostasis in DNA Damage Response
Proteostasis is essential for maintaining the proper function of the proteome and diverse cellular processes. The ubiquitin system plays a central role in proteostasis by regulating protein stability, trafficking, and termination. Under cellular stress, rapid proteome remodeling is required to maintain proteostasis and support adaptive cellular stress-response pathways, including the DNA damage response (DDR). Proper DDR function relies on precise control of protein abundance and signaling dynamics, primarily achieved through ubiquitin-mediated proteostatic regulation involving both proteolytic degradation and non-proteolytic scaffolding function. Dysregulation of the ubiquitin system alters the dynamic control of the DDR cascade, leading to genomic instability and disease progression. Therefore, targeting key components of the ubiquitin system may restore proper DDR signaling regulation and offer novel therapeutic opportunities for disease treatment. In this review, we summarize the role of the ubiquitin system in proteostasis-mediated DDR regulation and explore the potential of targeting ubiquitin system components as therapeutic strategies in cancer treatment.